{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:50:41Z","timestamp":1791355841292,"version":"4.3.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.semcancer.2010.09.005","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T09:31:34Z","timestamp":1285839094000},"page":"424-430","source":"Crossref","is-referenced-by-count":88,"title":["Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting"],"prefix":"10.1016","volume":"20","author":[{"given":"Jan A.","family":"Burger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2010.09.005_bib0005","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1096\/fasebj.2.11.2840318","article-title":"Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist","volume":"2","author":"Thelen","year":"1988","journal-title":"FASEB Journal"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0167-5699(95)80076-X","article-title":"Chemokines: new ligands, receptors and activities","volume":"16","author":"Kunkel","year":"1995","journal-title":"Immunology Today"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-2776(08)60910-4","article-title":"Chemokines and their receptors in lymphocyte traffic and HIV infection","volume":"74","author":"Loetscher","year":"2000","journal-title":"Advances in Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.272.5258.60","article-title":"Lymphocyte homing and homeostasis","volume":"272","author":"Butcher","year":"1996","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/33340","article-title":"Chemokines and leukocyte traffic","volume":"392","author":"Baggiolini","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/84219","article-title":"Lymphocyte traffic control by chemokines","volume":"2","author":"Moser","year":"2001","journal-title":"Nature Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0040","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nri2588","article-title":"Stromal cell contributions to the homeostasis and functionality of the immune system","volume":"9","author":"Mueller","year":"2009","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0050","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.279.5349.381","article-title":"Chemokines and the arrest of lymphocytes rolling under flow conditions","volume":"279","author":"Campbell","year":"1998","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0055","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0060","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.leu.2401602","article-title":"Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)","volume":"13","author":"Mohle","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0065","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.leu.2402107","article-title":"Differential expression of chemokine receptors in B cell malignancies","volume":"15","author":"Durig","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0070","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00277-003-0679-0","article-title":"CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease","volume":"82","author":"Barretina","year":"2003","journal-title":"Annals of Hematology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4065\/79.3.318","article-title":"Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"79","author":"Ghobrial","year":"2004","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0080","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V114.22.355.355","article-title":"Comparative gene expression profiling of leukemia cells in peripheral blood and tissue compartments reveals a prominent role of the microenvironment for CLL cell proliferation","volume":"114","author":"Herishanu","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0085","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2141.2007.06790.x","article-title":"B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle","volume":"139","author":"Bennett","year":"2007","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0090","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1182\/blood-2009-05-219634","article-title":"In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia","volume":"114","author":"Calissano","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0095","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V99.8.2977","article-title":"The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes","volume":"99","author":"Till","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0100","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1182\/blood-2003-09-3103","article-title":"Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas","volume":"104","author":"Trentin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0105","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Burger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0110","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1182\/blood-2004-03-0889","article-title":"Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha","volume":"106","author":"Nishio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0115","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1182\/blood-2005-04-1718","article-title":"ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)","volume":"107","author":"Richardson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0120","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1073\/pnas.91.6.2305","article-title":"Molecular cloning and structure of a pre-B-cell growth-stimulating factor","volume":"91","author":"Nagasawa","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0125","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2009-03-212837","article-title":"B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406","volume":"114","author":"Quiroga","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0130","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1158\/0008-5472.CAN-08-4750","article-title":"Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease","volume":"69","author":"Vlad","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0135","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","article-title":"Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia","volume":"100","author":"Chen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0140","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1182\/blood-2007-06-094029","article-title":"CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential","volume":"110","author":"Deaglio","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0145","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/leu.2010.36","article-title":"CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells","volume":"24","author":"Vaisitti","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0150","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2004-12-4918","article-title":"Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells","volume":"106","author":"Burger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0155","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1182\/blood-2008-06-165068","article-title":"Isoform-selective phosphoinositide 3\u2032-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach","volume":"113","author":"Niedermeier","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0160","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2009-07-233718","article-title":"Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance","volume":"114","author":"Kurtova","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V98.1.29","article-title":"Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy","volume":"98","author":"Rawstron","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/leu.2008.299","article-title":"CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers","volume":"23","author":"Burger","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0175","article-title":"Preliminary results from a phase I\/II dose escalation study to determine the maximum tolerated dose of plerixafor in combination with rituximab in patients with relapsed chronic lymphocytic leukemia","volume":"95","author":"Andritsos","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0180","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","article-title":"Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"115","author":"Friedberg","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0185","doi-asserted-by":"crossref","first-page":"8012a","DOI":"10.1200\/jco.2010.28.15_suppl.8012","article-title":"Effect of Btk inhibitor PCI-32765 monotherapy on responses in patients with relapsed aggressive NHL: evidence of antitumor activity from a phase I study","author":"Advani","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0190","doi-asserted-by":"crossref","first-page":"380a","DOI":"10.1182\/blood.V114.22.922.922","article-title":"Evidence of clinical activity in a phase 1 study of CAL-101, an oral P110 isoform-selective inhibitor of phosphatidylinositol 3-kinase, in patients with relapsed or refractory B-cell malignancies","volume":"114","author":"Flinn","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.immuni.2006.11.012","article-title":"Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing","volume":"26","author":"de Gorter","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ni1542","article-title":"Follicular shuttling of marginal zone B cells facilitates antigen transport","volume":"9","author":"Cinamon","year":"2008","journal-title":"Nature Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1034\/j.1600-065X.2003.00073.x","article-title":"The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity","volume":"195","author":"Muller","year":"2003","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0210","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/eji.1830221107","article-title":"Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma","volume":"22","author":"Dobner","year":"1992","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0215","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0092-8674(00)81798-5","article-title":"A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen","volume":"87","author":"Forster","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0220","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/35876","article-title":"A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1","volume":"391","author":"Gunn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0225","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni1100","article-title":"Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5","volume":"5","author":"Allen","year":"2004","journal-title":"Nature Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0230","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.1136736","article-title":"Imaging of germinal center selection events during affinity maturation","volume":"315","author":"Allen","year":"2007","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0235","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05573","article-title":"In vivo imaging of germinal centres reveals a dynamic open structure","volume":"446","author":"Schwickert","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0240","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2006.10.011","article-title":"Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes","volume":"25","author":"Bajenoff","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0245","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.4049\/jimmunol.177.5.2749","article-title":"B-1 B cell development","volume":"177","author":"Hardy","year":"2006","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0250","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1084\/jem.155.2.623","article-title":"Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia","volume":"155","author":"Caligaris-Cappio","year":"1982","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0255","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1084\/jem.193.12.1393","article-title":"Aberrant high expression of B lymphocyte chemokine (BLC\/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC","volume":"193","author":"Ishikawa","year":"2001","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1074-7613(01)00257-6","article-title":"CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity","volume":"16","author":"Ansel","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0265","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1182\/blood-2006-12-064345","article-title":"The peritoneal micromilieu commits B cells to home to body cavities and the small intestine","volume":"109","author":"Berberich","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0270","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V95.2.627","article-title":"The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia","volume":"95","author":"Jones","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0275","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1189\/jlb.1203652","article-title":"Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination","volume":"76","author":"Lopez-Giral","year":"2004","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0280","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2007-05-089409","article-title":"Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia","volume":"110","author":"Burkle","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0285","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri1786","article-title":"Lymphoid neogenesis in chronic inflammatory diseases","volume":"6","author":"Aloisi","year":"2006","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0290","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80199-5","article-title":"BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis","volume":"12","author":"Luther","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0295","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1749-6632.2009.04813.x","article-title":"CXCR3, inflammation, and autoimmune diseases","volume":"1173","author":"Lacotte","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0300","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W","article-title":"Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization","volume":"28","author":"Loetscher","year":"1998","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0305","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI7335","article-title":"The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis","volume":"104","author":"Trentin","year":"1999","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0310","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3324\/haematol.10649","article-title":"The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells","volume":"92","author":"Ocana","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0315","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"Forster","year":"2008","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0320","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ccr.2007.04.020","article-title":"Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling","volume":"11","author":"Shields","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0325","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1189\/jlb.0709505","article-title":"CCR7 regulates lymphocyte egress and recirculation through body cavities","volume":"87","author":"Hopken","year":"2010","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0330","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood-2007-08-107300","article-title":"Matrix metalloproteinase-9 is up-regulated by CCL21\/CCR7 interaction via extracellular signal-regulated kinase-1\/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration","volume":"111","author":"Redondo-Munoz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0495","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.exphem.2010.05.003","article-title":"Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines Ccl19 and Ccl21 in B-chronic lymphocytic leukemia","volume":"38","author":"Cuesta-Mateos","year":"2010","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0340","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1189\/jlb.1105623","article-title":"Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia","volume":"79","author":"Alfonso-Perez","year":"2006","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0345","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1084\/jem.177.6.1821","article-title":"Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes","volume":"177","author":"Schall","year":"1993","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0350","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.162.8.4455","article-title":"Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells","volume":"162","author":"Krzysiek","year":"1999","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0355","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1101\/sqb.1999.64.71","article-title":"The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes","volume":"64","author":"Alizadeh","year":"1999","journal-title":"Cold Spring Harbor Symposia on Quantitative Biology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0360","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI40645","article-title":"Comprehensive assessment of chemokine expression profiles by flow cytometry","volume":"120","author":"Eberlein","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0365","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","article-title":"BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control","volume":"13","author":"Shaffer","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0370","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0375","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0380","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"Lossos","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0385","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/leu.2009.130","article-title":"Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma","volume":"23","author":"Roussou","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0390","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2141.2003.04561.x","article-title":"Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma","volume":"123","author":"Terpos","year":"2003","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0395","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","article-title":"High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation","volume":"113","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0400","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-08-4173","article-title":"CD38\/CD31, the CCL3 and CCL4 chemokines, and CD49d\/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival","volume":"69","author":"Zucchetto","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0405","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1182\/blood-2009-12-257758","article-title":"High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease","volume":"115","author":"Palacios","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0410","first-page":"63","article-title":"Role of CCL3 protein (monocyte inflammatory protein-1 alpha) in lymphoid malignancy","volume":"14","author":"Hamed","year":"2007","journal-title":"The Egyptian Journal of Immunology\/Egyptian Association of Immunologists"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0415","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1182\/blood-2004-10-3873","article-title":"CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival","volume":"105","author":"Deaglio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0420","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1182\/blood-2009-06-228981","article-title":"The lymphatic tissue microenvironments in chronic lymphocytic leukemia: in vitro models and the significance of CD40\u2013CD154 interactions","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0425","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.4049\/jimmunol.169.12.6673","article-title":"Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells","volume":"169","author":"Penna","year":"2002","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0430","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ni735","article-title":"B cells and professional APCs recruit regulatory T cells via CCL4","volume":"2","author":"Bystry","year":"2001","journal-title":"Nature Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0435","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04651","article-title":"Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction","volume":"440","author":"Castellino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0440","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y","article-title":"Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22","volume":"32","author":"Ghia","year":"2002","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0445","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2007-08-108605","article-title":"CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment","volume":"111","author":"Patten","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0450","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V99.3.1030","article-title":"Distinctive features of \u201cnurselike\u201d cells that differentiate in the context of chronic lymphocytic leukemia","volume":"99","author":"Tsukada","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0455","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0460","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-08-2360","article-title":"Regulatory T cells recruited through CCL22\/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome","volume":"69","author":"Gobert","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0465","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1158\/0008-5472.CAN-06-0261","article-title":"Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege","volume":"66","author":"Ishida","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0470","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood-2007-04-084756","article-title":"The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells","volume":"112","author":"Luqman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0475","doi-asserted-by":"crossref","first-page":"13408","DOI":"10.1073\/pnas.0701553104","article-title":"IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival","volume":"104","author":"Binsky","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0480","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1365-2141.2003.04118.x","article-title":"Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia","volume":"120","author":"Wierda","year":"2003","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0485","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nature03703","article-title":"In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment","volume":"435","author":"Sipkins","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2010.09.005_bib0490","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ni.f.210","article-title":"Moving targets: cell migration inhibitors as new anti-inflammatory therapies","volume":"9","author":"Mackay","year":"2008","journal-title":"Nature Immunology"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X10000830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X10000830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T15:04:04Z","timestamp":1685804644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X10000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1044579X10000830"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2010.09.005","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}